Table 4.
Availability of anticancer medicines in public and private sectors in Punjab, Pakistan
| Sr. No | Medicine and Dose | Public hospitals (n = 18) | Private hospitals (n = 4) | Private pharmacies (n = 44) | All (n = 66) | ||||
|---|---|---|---|---|---|---|---|---|---|
| OB | LPG | OB | LPG | OB | LPG | OB | LPG | ||
| 1 | Anastrozole 1 mg tab | 0 (0.0) | 0 (0.0) | 1 (25.0) | 0 (0.0) | 4 (9.1) | 2 (4.5) | 5 (7.6) | 2 (3.0) |
| 2 | Bicalutamide 50 mg tab | 0 (0.0) | 0 (0.0) | 1 (25.0) | 0 (0.0) | 3 (6.8) | 1 (2.3) | 4 (6.1) | 1 (1.5) |
| 3 | Bleomycin 15 mg inj | 10 (55.6) | 8 (44.4) | 4(100) | 2 (50.0) | 41 (93.2) | 27 (61.4) | 55 (83.3) | 37 (56.1) |
| 4 | Capecitabine 500 mg tab | 4 (22.2) | NA | 4 (100) | NA | 21 (47.7) | NA | 29 (44.0) | NA |
| 5 | Carboplatin 150 mg inj | 13 (72.2) | 5 (27.8) | 4(100) | 1 (25.0) | 33 (75.0) | 29 (65.9) | 50 (76.0) | 35 (53.0) |
| 6 | Cisplatin 50 mg inj | 8 (44.4) | 9 (50.0) | 3 (75.0) | 0 (0.0) | 43 (97.7) | 11 (25.0) | 54 (82.0) | 20 (30.3) |
| 7 | Cyclophosphamide 500 mg inj | 15 (83.3) | 3 (16.7) | 4 (100) | 0 (0.0) | 41 (93.2) | 9 (20.5) | 60 (91.0) | 12 (18.2) |
| 8 | Cyproterone Acetate 50 mg tab | 7 (38.9) | NA | 4 (100) | NA | 39 (88.6) | NA | 50 (76.0) | NA |
| 9 | Cytarabine 100 mg inj | 3 (16.7) | 0 (0.0) | 3 (75.0) | 1 (25.0) | 34 (77.3) | 7 (15.9) | 40 (61.0) | 8 (12.1) |
| 10 | Dacarbazine 200 mg inj | 4 (22.2) | 1 (5.6) | 2 (50.0) | 1 (25.0) | 27 (61.4) | 13 (29.5) | 33 (50.0) | 15 (22.7) |
| 11 | Dactinomycin 0.5 mg inj | 8 (44.4) | 2 (11.1) | 3 (75.0) | 1 (25.0) | 42(95.5) | 31 (70.5) | 53 (80.3) | 34 (51.5) |
| 12 | Daunomycin 20 mg inj | 2 (11.1) | 0 (0.0) | 1 (25.0) | 1 (25.0) | 16(36.4) | 11 (25.0) | 19 (29.0) | 12 (18.2) |
| 13 | Docetaxil 80 mg inj | 7 (38.9) | 0 (0.0) | 3 (75.0) | 0 (0.0) | 33(75.0) | 7 (15.9) | 43 (65.1) | 7 (10.6) |
| 14 | Doxorubicin 50 mg inj | 14 (77.8) | 4 (22.2) | 4 (100) | 2 (50.0) | 44(100) | 31(70.5) | 62 (94.0) | 37 (56.1) |
| 15 | Epirubicin 50 mg inj | 2 (11.1) | 3 (16.7) | 4 (100) | 1 (25.0) | 14(31.8) | 9 (20.5) | 20 (30.3) | 13 (19.7) |
| 16 | Etoposide 100 mg inj | 15 (83.3) | 0 (0.0) | 4 (100) | 0 (0.0) | 44(100) | 13 (29.5) | 63 (95.4) | 13 (19.7) |
| 17 | Fludarabine phosphate 50 mg inj | 0 (0.0) | 0 (0.0) | 4 (100) | 1 (25.0) | 11(25.0) | 4 (9.9) | 15 (23.0) | 5 (7.6) |
| 18 | Flourouracil 500 mg inj | 16 (88.9) | 0 (0.0) | 4 (100) | 2 (50.0) | 44(100) | 19 (43.2) | 64 (97.0) | 21 (31.8) |
| 19 | Gemicitabine 1 g inj | 5 (27.8) | 11 (61.1) | 4 (100) | 2 (50.0) | 31(70.5) | 41 (93.2) | 40 (61.0) | 54 (81.8) |
| 20 | Hydroxyurea 500 mg cap | 7 (38.9) | 0 (0.0) | 3 (75.0) | 0 (0.0) | 23(52.3) | 11 (25.0) | 33 (50.0) | 11 (16.7) |
| 21 | Ifosfamide I gminj | 5 (27.8) | 2 (11.1) | 2 (50.0) | 0 (0.0) | 19(42.3) | 21 (47.7) | 26 (39.4) | 21 (31.8) |
| 22 | Imatinibmesylate 400 mg tab | 0 (0.0) | NA | 3 (75.0) | NA | 15(34.1) | NA | 18 (27.3) | NA |
| 23 | Irinotecan 100 mg inj | 0 (0.0) | 0 (0.0) | 2 (50.0) | 0 (0.0) | 11(25.0) | 10 (22.7) | 13 (20.0) | 10 (15.2) |
| 24 | Lapatinib 250 mg tab | 0 (0.0) | NA | 2 (50.0) | NA | 13(29.6) | NA | 15 (23.0) | NA |
| 25 | Letrozole 2.5 mg tab | 0 (0.0) | 0 (0.0) | 2 (50.0) | 0 (0.0) | 16(36.4) | 8 (18.2) | 18 (27.2) | 8 (12.1) |
| 26 | Mercaptopurine 50 mg tab | 13 (72.2) | 3 (16.7) | 4 (100) | 0 (0.0) | 41(93.2) | 11 (25.0) | 58 (88.0) | 14 (21.2) |
| 27 | Methotrexate 10 mg tab | 15 (83.3) | 1 (5.6) | 4 (100) | 1 (25.0) | 44(100) | 19 (43.2) | 63 (95.4) | 21 (31.8) |
| 28 | Mitomycin 10 mg inj | 2 (11.1) | 0 (0.0) | 2 (50.0) | 1 (25.0) | 31(70.5) | 12 (27.3) | 35 (53.0) | 13 (19.7) |
| 29 | Mitoxantrone 20 mg inj | 0 (0.0) | NA | 3 (75.0) | NA | 18 (40.9) | NA | 21 (32.0) | NA |
| 30 | Nilotinib 200 mg cap | 0 (0.0) | NA | 3 (75.0) | NA | 19 (43.2) | NA | 22 (33.3) | NA |
| 31 | Oxaliplatin 100 mg inf | 1 (5.6) | 0 (0.0) | 2 (50.0) | 2 (50.0) | 21 (47.7) | 11 (25.0) | 24 (36.4) | 13 (19.7) |
| 32 | Paclitaxel 260 mg inf | 11 (61.1) | 4 (22.2) | 3 (75.0) | 1 (25.0) | 44 (100) | 23 (52.3) | 58 (88.0) | 28 (42.4) |
| 33 | Pazopanib 400 mg tab | 0 (0.0) | NA | 1 (25.0) | NA | 4 (9.1) | NA | 5 (7.6) | NA |
| 34 | Sorfenib 200 mg tab | 0 (0.0) | NA | 1 (25.0) | NA | 5(11.4) | NA | 6 (9.1) | NA |
| 35 | Sunitinib 50 mg cap | 0 (0.0) | NA | 0 (0.0) | NA | 3 (6.8) | NA | 3 (4.5) | NA |
| 36 | Tamoxifen 20 mg tab | 15 (83.3) | 2 (11.1) | 4 (100) | 2 (50.0) | 44(100) | 16 (36.4) | 63 (95.4) | 20 (30.3) |
| 37 | Thalidomide 100 mg cap | 4 (22.2) | NA | 4 (100) | NA | 25 (56.8) | NA | 33 (50.0) | NA |
| 38 | Vinblastine 10 mg inj | 9 (50.0) | 3 (16.7) | 4 (100) | 0 (0.0) | 31(70.5) | 19 (43.2) | 44 (67.0) | 34 (51.5) |
| 39 | Vincristine 2 mg inj | 11 (61.1) | 2 (11.1) | 3 (75.0) | 0 (0.0) | 33 (75.0) | 23 (52.3) | 47 (71.2) | 25 (37.9) |
| 40 | Vinorelbine 50 mg inj | 0 (0.0) | 0 (0.0) | 2 (50.0) | 2 (50.0) | 21 (47.7) | 11 (25.0) | 23 (35.0) | 13 (19.7) |
| Total | 31.4% | 11.7% | 71.9% | 20.0% | 59.4% | 34.9% | 52.5% | 28.1% | |
OB = Originator brand; LPG = Lowest price generic; NA = Not available